J Korean Soc Transplant.  2002 Dec;16(2):244-245.

Liver Transplantation for Hepatocellular Carcinoma: Single Center Experience for Seventeen Years

Affiliations
  • 1Department of Surgery, Dong-A University, College of Medicine, Busan, Korea. yhkim1@daunet.donga.ac.kr
  • 2Princess Alexandra Hospital Queensland Liver Transplant Service Brisbane, Austrailia.

Abstract

PURPOSE: Surgical Treatment of hepatocellular carcinoma in patients with cirrhosis is not clearly defined. The objective of this study was to assess the patient long term survival and determine the prognostic factor.
METHODS
30 patients seen between 1985 and 2001 were identified in a prospective data-base. Data about the race, cause of cirrhosis, pre-transplant treatment, size, macrovascular invasion and long-term outcome were examined.
RESULTS
Overall survival rate for 1, 3 and 5 year was 81.4%, 72.3% and 50.9% respectively. races, etiology of cirrhosis, pretransplant treatment, macrovascular invasion did not affect the outcome. Only the size of hepatocellular carcinoma (4 cm) influenced the survival.
CONCLUSION
This study showed that overall survival rate of liver transplantation for cirrhosis associated heaptocellular carcinoma is similar to those with cirrhosis alone. Only the size of tumor affected the outcome.

Keyword

Hepatocellular carcinoma; Liver transplantation

MeSH Terms

Carcinoma, Hepatocellular*
Continental Population Groups
Fibrosis
Humans
Liver Transplantation*
Liver*
Prospective Studies
Survival Rate
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr